WASHINGTON: President Donald Trump plans to inform trading partners of unilateral US tariff rates in the coming weeks, as a July deadline approaches for steeper levies to kick in on dozens of ...

The Company is currently testing PAS-004 in a Phase 1 clinical trial in advanced cancer patients (NCT06299839), and a Phase 1/1b clinical trial in adult patients with neurofibromatosis type 1 (NF1 ...

EPS: CA$0.004 (down from CA$0.009 in 3Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.